Nederlandse reactie op gerichte consultatie over herziening EMA-vergoedingensysteem

Experts say pulse oximeters are less accurate when used on darker skin, prompting calls for improvements in the devices. Throughout the COVID-19 pandemic, pulse oximeters have been a common tool to measure blood oxygen...

The European Commission (EC) has issued a marketing authorisation for Sanofi Genzyme’s therapy Nexviadyme (avalglucosidase alfa) for the long-term treatment of both late-onset and infantile-onset Pompe disease. Pompe...

AbbVie has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for atogepant as a migraine treatment for adults who have at least four migraine days per month. Atogepant is an...